Purpose: To evaluate clinical outcomes including changes in high-order aberrations (HOAs), after cataract surgery using a monofocal extended-depth-of-focus (EDoF) intraocular lens (IOL) in patients with retinal diseases. Methods: A total of 29 eyes of 26 patients with cataract and retinal disease underwent cataract surgery using a monofocal EDoF IOL (TECNIS Eyhance® ICB00). The improvement in high-order aberrations, visual discomfort, and intermediate visual acuity after the surgery were investigated. Results: The total ocular HOA, internal HOA, and coma aberration were significantly reduced from 0.390 ± 0.225 μm, 0.346 ± 0.275 μm, and 0.228 ± 0.184 μm, respectively before the surgery, to 0.214 ± 0.108 μm, 0.218 ± 0.111 μm, and 0.101 ± 0.076 μm 3 months after the surgery. Trefoil and spherical aberrations were reduced from 0.167 ± 0.109 μm, 0.046 ± 0.155 μm to 0.107 ± 0.091 μm, 0.003 ± 0.055 μm respectively after the surgery, but not statistically significant (p = 0.059, p = 0.154). In the analysis of potential visual complaints, Blur/ Double vision, Glare/Halo and Starburst score were 1.35 ± 1.23, 0.72 ± 1.00 and 1.21 ± 1.18 preoperatively, and 0.41 ± 0.87, 0.17 ± 0.38, and 0.52 ± 0.74 postoperatively. They all showed statistically significant decreases (p < 0.001, p = 0.011, p = 0.024). At 3 months after surgery, intermediate visual acuity converted to logarithm of the minimal angle of resolution (LogMAR) was LogMAR 0.29 ± 0.31 and the median visual acuity was 0.19. Conclusions In patients with cataracts combined with retinal disease, a significant reduction in HOAs and visual discomfort were observed after cataract surgery using monofocal EDoF IOLs.

Purpose: To quantitatively analyze the effects of various oral supplements on changes in hard exudates in patients with diabetic retinopathy. Methods: The medical records of patients with diabetic retinopathy with hard exudates who were taking one type of oral supplement for more than 12 months were retrospectively analyzed. Patients were divided into Vitis vinifera seed dried extract (Enteron® ), Vaccinium myrtillus extract (Qretin® ), and sulodexide (Vessel Due F® ) groups according to the oral supplement taken. Optical coherence tomography was analyzed using an automated program to measure and compare the volume of hard exudates. Results: The Enteron® group included 44 eyes 31 patients, the Qretin® group included 35 eyes 25 patients, and the Vessel Due F®group included 22 eyes 15 patients. After 12 months of oral supplementation, hard exudates decreased in all oral supplement groups, but only the Qretin® group showed a significant decrease, from 0.08910 ± 0.08958 mm 3 to 0.04773 ± 0.05473 mm 3 . Changes in hard exudates were not significantly different among the oral supplement groups. In multivariate regression analysis, the larger was the volume of hard exudates before oral supplementation, the greater was the decrease in volume after 12 months of oral supplementation. Conclusions Vaccinium myrtillus extract supplementation for 12 months was associated with improvement in hard exudates in diabetic retinopathy. However, there was no difference in the change of hard exudates across the three groups.

Purpose: To analyze changes in choroidal thickness in patients with recurrent rhegmatogenous retinal detachment (RRD) before and after surgical intervention and to identify factors that influence changes in choroidal thickness. Methods: A retrospective observational study was conducted on patients who underwent surgery for recurrent RRD from November 2019 to March 2023. Choroidal thickness was measured using optical coherence tomography at baseline and at 2 and 6 months postoperatively. The study analyzed the impact of various factors on choroidal thickness changes. Results: The study included 33 patients, demonstrating a significant decrease in choroidal thickness in the surgical eye compared to the fellow eye over a 6-month period. In the univariate analysis, changes in choroidal thickness were significantly correlated with changes in central retinal thickness (p = 0.048) from baseline to 2 months and with proliferative vitreoretinopathy (PVR) grade from 2 to 6 months (p = 0.009) and from baseline to 6 months (p = 0.020). In the multivariate analysis, an association was found between changes in choroidal thickness from 2 to 6 months and PVR grade (p = 0.030) Conclusions The findings indicate that surgical reattachment in eyes with recurrent RRD leads to a significant reduction in choroidal thickness. The extent of this reduction is influenced by the severity of PVR, highlighting the importance of considering PVR severity when evaluating surgical outcomes in patients with recurrent RRD.

Purpose: To analyze changes in choroidal thickness in patients with recurrent rhegmatogenous retinal detachment (RRD) before and after surgical intervention and to identify factors that influence changes in choroidal thickness. Methods: A retrospective observational study was conducted on patients who underwent surgery for recurrent RRD from November 2019 to March 2023. Choroidal thickness was measured using optical coherence tomography at baseline and at 2 and 6 months postoperatively. The study analyzed the impact of various factors on choroidal thickness changes. Results: The study included 33 patients, demonstrating a significant decrease in choroidal thickness in the surgical eye compared to the fellow eye over a 6-month period. In the univariate analysis, changes in choroidal thickness were significantly correlated with changes in central retinal thickness (p = 0.048) from baseline to 2 months and with proliferative vitreoretinopathy (PVR) grade from 2 to 6 months (p = 0.009) and from baseline to 6 months (p = 0.020). In the multivariate analysis, an association was found between changes in choroidal thickness from 2 to 6 months and PVR grade (p = 0.030) Conclusions The findings indicate that surgical reattachment in eyes with recurrent RRD leads to a significant reduction in choroidal thickness. The extent of this reduction is influenced by the severity of PVR, highlighting the importance of considering PVR severity when evaluating surgical outcomes in patients with recurrent RRD.

Purpose: To analyze changes in choroidal thickness in patients with recurrent rhegmatogenous retinal detachment (RRD) before and after surgical intervention and to identify factors that influence changes in choroidal thickness. Methods: A retrospective observational study was conducted on patients who underwent surgery for recurrent RRD from November 2019 to March 2023. Choroidal thickness was measured using optical coherence tomography at baseline and at 2 and 6 months postoperatively. The study analyzed the impact of various factors on choroidal thickness changes. Results: The study included 33 patients, demonstrating a significant decrease in choroidal thickness in the surgical eye compared to the fellow eye over a 6-month period. In the univariate analysis, changes in choroidal thickness were significantly correlated with changes in central retinal thickness (p = 0.048) from baseline to 2 months and with proliferative vitreoretinopathy (PVR) grade from 2 to 6 months (p = 0.009) and from baseline to 6 months (p = 0.020). In the multivariate analysis, an association was found between changes in choroidal thickness from 2 to 6 months and PVR grade (p = 0.030) Conclusions The findings indicate that surgical reattachment in eyes with recurrent RRD leads to a significant reduction in choroidal thickness. The extent of this reduction is influenced by the severity of PVR, highlighting the importance of considering PVR severity when evaluating surgical outcomes in patients with recurrent RRD.

Purpose: To analyze changes in choroidal thickness in patients with recurrent rhegmatogenous retinal detachment (RRD) before and after surgical intervention and to identify factors that influence changes in choroidal thickness. Methods: A retrospective observational study was conducted on patients who underwent surgery for recurrent RRD from November 2019 to March 2023. Choroidal thickness was measured using optical coherence tomography at baseline and at 2 and 6 months postoperatively. The study analyzed the impact of various factors on choroidal thickness changes. Results: The study included 33 patients, demonstrating a significant decrease in choroidal thickness in the surgical eye compared to the fellow eye over a 6-month period. In the univariate analysis, changes in choroidal thickness were significantly correlated with changes in central retinal thickness (p = 0.048) from baseline to 2 months and with proliferative vitreoretinopathy (PVR) grade from 2 to 6 months (p = 0.009) and from baseline to 6 months (p = 0.020). In the multivariate analysis, an association was found between changes in choroidal thickness from 2 to 6 months and PVR grade (p = 0.030) Conclusions The findings indicate that surgical reattachment in eyes with recurrent RRD leads to a significant reduction in choroidal thickness. The extent of this reduction is influenced by the severity of PVR, highlighting the importance of considering PVR severity when evaluating surgical outcomes in patients with recurrent RRD.

Purpose: To analyze changes in choroidal thickness in patients with recurrent rhegmatogenous retinal detachment (RRD) before and after surgical intervention and to identify factors that influence changes in choroidal thickness. Methods: A retrospective observational study was conducted on patients who underwent surgery for recurrent RRD from November 2019 to March 2023. Choroidal thickness was measured using optical coherence tomography at baseline and at 2 and 6 months postoperatively. The study analyzed the impact of various factors on choroidal thickness changes. Results: The study included 33 patients, demonstrating a significant decrease in choroidal thickness in the surgical eye compared to the fellow eye over a 6-month period. In the univariate analysis, changes in choroidal thickness were significantly correlated with changes in central retinal thickness (p = 0.048) from baseline to 2 months and with proliferative vitreoretinopathy (PVR) grade from 2 to 6 months (p = 0.009) and from baseline to 6 months (p = 0.020). In the multivariate analysis, an association was found between changes in choroidal thickness from 2 to 6 months and PVR grade (p = 0.030) Conclusions The findings indicate that surgical reattachment in eyes with recurrent RRD leads to a significant reduction in choroidal thickness. The extent of this reduction is influenced by the severity of PVR, highlighting the importance of considering PVR severity when evaluating surgical outcomes in patients with recurrent RRD.

Purpose: To report a modified rectangular loop suture technique for patients with refractory pupillary optic capture after intraocular lens scleral fixation. Methods: A modified rectangular loop suture was performed in four patients with persistent pupillary capture despite medication and laser iridotomy. A loop suture pattern was designed in the two quadrants without the scleral fixation knot. A 2 mm loop suture point was marked 2 mm away from the corneal limbus. The suture point was similarly marked in the opposite quadrants. Small conjunctival incisions were made at a marked point and a non-absorbable 10-0 prolene long needle was passed. The needle was inserted at the 1 o’clock position through the conjunctival incision and passed between the intraocular lens and the iris plane. Then it was withdrawn using a 26-gauge (G) syringe from the 8 o’clock position in the opposite quadrant. Similarly, the needle was passed from the 7 o’clock position under the conjunctiva, and pulled out of the sclera at the 2 o’clock position. It was then passed to the 1 o’clock position under the conjunctiva and a knot was made and buried. The operation was completed without closure of the conjunctival incision. Results: In all four eyes, pupillary optic capture was corrected and remained stable without recurrence for an average of 7.25 months. Conclusions The modified rectangular loop suture may be useful for refractory pupillary capture cases. The procedure is relatively simple and minimizes scleral exposure to the conjunctival suture. It is expected that this may reduce patient discomfort.

Purpose: To investigate the characteristics and treatment results of patients aged ≥ 85 years who were diagnosed with treatment-naïve neovascular age-related macular degeneration (nAMD). Methods: The medical records of patients diagnosed with treatment-naïve nAMD who were ≥ 85 years old at the time of diagnosis with at least 12 months follow-up were retrospectively reviewed. The number of intravitreal injections of anti-vascular endothelial growth factor (VEGF) and agents used during the entire period were investigated. Best-corrected visual acuity and optical coherence tomography results before and after treatment were analyzed. Visual acuity of the fellow eye was also collected. Results: A total of 40 eyes of 40 patients with mean age of 87.5 ± 2.4 were included in the study. The mean logarithm of the minimal angle of resolution visual acuity was 0.85 ± 0.57, and the mean of the fellow eye was 0.93 ± 0.99. Compared to before the treatment, there was no significant difference after intravitreal injection in terms of visual acuity. Central retinal thickness showed significant reduction at all time points after treatment. Conclusions In patients aged ≥ 85 years at the time of diagnosis, intravitreal injections of anti-VEGF prevented deterioration of visual acuity and showed successful anatomical outcomes. Especially, many had poor visual acuity in the fellow eye, suggesting the importance of maintaining visual acuity. Therefore, active treatment is necessary in the elderly.

Purpose: We compared corneal higher-order aberration (HOA) measurements between the Pentacam® HR (PC), which uses the Scheimpflug principle, and the iTraceTM aberrometer (IT), which evaluates Placido disc topography. Methods: We retrospectively analyzed 109 eyes of 87 patients without a history of ocular surface disease during the period from January 2021 to December 2022; both devices were used on the same day. We calculated the root mean square values (μm) of corneal total HOA and of the corneal 3rd- and 4th-order HOA at a pupil diameter of 4 mm. Data were compared by Bland-Altman plots for agreement analysis and Pearson correlation coefficient for correlation analysis. Results: There was no significant difference in the total HOA (p = 0.145), coma (p = 0.309), or secondary astigmatism (p = 0.080) between the PC and IT measurements; all other HOAs significantly differed between devices (p < 0.001). In the correlation analysis, the total HOA (r = 0.605, p < 0.001) and coma (r = 0.634, p < 0.001) were moderately correlated between the two devices; the other HOAs showed low degree of correlations. In the Bland-Altman plot analysis, all HOAs showed low agreement between the two devices. Conclusions Corneal total HOA and coma measured by the two devices were significantly correlated between the two devices, but other HOAs showed significant differences in measurement and low correlations. Therefore, corneal HOA measurements cannot be interpreted interchangeably between the two devices.